NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr | ₹-251 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-247 Cr |
Mar2023 | ₹-363 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹-186 Cr |
Mar2020 | ₹-251 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-247 Cr | Negative | |
Mar2023 | ₹-363 Cr | Negative | |
Mar2022 | ₹35 Cr | Positive | |
Mar2021 | ₹-186 Cr | Negative | |
Mar2020 | ₹-251 Cr | - |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,042.3 Cr | -4.6% | -38.8% | -22.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,213.0 Cr | 3.9% | -3.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,403.0 Cr | 1.8% | -4.5% | 53.9% | Stock Analytics | |
CIPLA | ₹117,415.0 Cr | -0.6% | -0.3% | -2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,791.0 Cr | 1.2% | -3% | 14.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,228.2 Cr | -3% | -9.5% | -11.7% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -4.6% |
-38.8% |
-22.3% |
SENSEX | 0.4% |
-4.9% |
-0.1% |
You may also like the below Video Courses